Healthy Extracts (HYEX) Other Non Operating Income (2016 - 2025)
Healthy Extracts' (HYEX) quarterly Other Non Operating Income came in at $205587.0 in Q4 2025, up 408.84% year-on-year from $40402.9 in Q4 2024, and up 70.06% quarter-over-quarter from $120891.0 in Q3 2025.
Healthy Extracts (HYEX) Other Non Operating Income (2016 - 2025) Analysis & Trends
Healthy Extracts' Other Non Operating Income history runs 10 years deep, the most recent figure standing at $205587.0 for Q4 2025.
- On a quarterly basis, Other Non Operating Income rose 408.84% year-over-year to $205587.0 in Q4 2025; TTM through Dec 2025 was $273010.0, a 171.36% increase from a year earlier, with the FY2025 full-year figure at $273010.0, up 157.93% from the prior year.
- Other Non Operating Income grew to $205587.0 in Q4 2025 per HYEX's latest filing, from $120891.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $309037.0 in Q3 2024 and bottomed at -$799185.0 in Q1 2024.
- The 5-year median for Other Non Operating Income is -$21388.5 (2023), against an average of -$43103.8.
- Across the five-year window, Other Non Operating Income slumped 3283.13% in 2021 and surged 1157.44% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at -$97945.0 in 2021, then jumped by 278.4% to $174729.0 in 2022, then tumbled by 132.41% to -$56627.0 in 2023, then slipped by 17.55% to -$66567.0 in 2024, then soared by 408.84% to $205587.0 in 2025.
- Per Business Quant, the three latest HYEX Other Non Operating Income figures stand at $205587.0 (Q4 2025), $120891.0 (Q3 2025), and $201986.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 205,587.00 |
| Sep 30, 2025 | 120,891.00 |
| Jun 30, 2025 | 201,986.00 |
| Mar 31, 2025 | -255,454.00 |
| Dec 31, 2024 | -66,567.00 |
| Sep 30, 2024 | 309,037.00 |
| Jun 30, 2024 | 174,156.00 |
| Mar 31, 2024 | -799,185.00 |
| Dec 31, 2023 | -56,627.00 |
| Sep 30, 2023 | 37,371.00 |
| Jun 30, 2023 | 13,850.00 |
| Mar 31, 2023 | -173,968.00 |
| Dec 31, 2022 | 174,729.00 |
| Sep 30, 2022 | -104,421.00 |
| Jun 30, 2022 | -220,817.00 |
| Mar 31, 2022 | 48,664.00 |
| Dec 31, 2021 | -97,945.00 |
| Sep 30, 2021 | -287,155.00 |
| Dec 31, 2020 | 3,077.00 |
| Sep 30, 2020 | 1.91 Mn |